National Research Corporation $NRC Stock Holdings Lifted by Quantinno Capital Management LP

Quantinno Capital Management LP raised its position in shares of National Research Corporation (NASDAQ:NRC) by 61.3% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 62,329 shares of the company’s stock after purchasing an additional 23,682 shares during the period. Quantinno Capital Management LP owned 0.27% of National Research worth $1,058,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. Hotchkis & Wiley Capital Management LLC increased its holdings in National Research by 7.9% in the third quarter. Hotchkis & Wiley Capital Management LLC now owns 292,400 shares of the company’s stock worth $3,737,000 after buying an additional 21,450 shares during the last quarter. Bank of New York Mellon Corp raised its position in National Research by 4.0% during the first quarter. Bank of New York Mellon Corp now owns 250,707 shares of the company’s stock valued at $4,257,000 after acquiring an additional 9,730 shares in the last quarter. Heartland Advisors Inc. lifted its stake in National Research by 374.3% in the first quarter. Heartland Advisors Inc. now owns 237,147 shares of the company’s stock valued at $4,027,000 after acquiring an additional 187,147 shares during the last quarter. AQR Capital Management LLC lifted its stake in National Research by 86.2% in the second quarter. AQR Capital Management LLC now owns 201,396 shares of the company’s stock valued at $3,383,000 after acquiring an additional 93,262 shares during the last quarter. Finally, Bank of America Corp DE grew its position in National Research by 5.8% in the second quarter. Bank of America Corp DE now owns 122,344 shares of the company’s stock worth $2,055,000 after acquiring an additional 6,690 shares in the last quarter. 47.26% of the stock is owned by hedge funds and other institutional investors.

National Research Stock Down 0.6%

Shares of NRC stock opened at $21.19 on Friday. The stock’s 50 day simple moving average is $20.63 and its 200 day simple moving average is $18.24. National Research Corporation has a twelve month low of $11.01 and a twelve month high of $23.68. The company has a debt-to-equity ratio of 13.13, a quick ratio of 0.65 and a current ratio of 0.65. The company has a market capitalization of $482.07 million, a price-to-earnings ratio of 84.76 and a beta of 0.34.

National Research (NASDAQ:NRC) last announced its earnings results on Tuesday, July 28th. The company reported $0.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.46. National Research had a return on equity of 164.26% and a net margin of 4.18%.The firm had revenue of $35.39 million during the quarter, compared to analysts’ expectations of $34.90 million.

National Research Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 9th. Stockholders of record on Friday, September 25th will be paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 3.0%. The ex-dividend date is Friday, September 25th. National Research’s payout ratio is presently 256.00%.

Analyst Ratings Changes

NRC has been the topic of several analyst reports. Citizens Jmp increased their price target on shares of National Research from $23.00 to $26.00 and gave the stock a “market outperform” rating in a research note on Wednesday, July 29th. Wall Street Zen lowered shares of National Research from a “buy” rating to a “hold” rating in a research note on Saturday. Finally, Weiss Ratings cut shares of National Research from a “hold (c-)” rating to a “sell (d+)” rating in a report on Thursday, August 6th. One investment analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $26.00.

National Research Profile

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.